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C-reactive protein (CRP)' was first described in 1930 by Tillet and Francis (2) who
observed that sera from patients during acute febrile illnesses had the ability to
precipitate the C-substance (later designated C-polysaccharide, CPS) of pneumococcal
cell walls. The serum factor responsible for this reaction was defined as a "C-precipitin,"
and later designated "C-reactive protein" (3) . This protein was found to appear in the
blood during a variety of reactions of tissue destruction or inflammation (3), and has
served as a useful clinical index of these processes (4-6). CRP was purified by MacLeod
and Avery (7, 8) who also demonstrated the calcium dependency of its binding to CPS,
and was later crystallized by McCarty (9). More recently, human CRP has been shown to
be a gamma-migrating protein (10) (mol wt approximately 120,000 daltons [11-13])
consisting of six identical, noncovalently bound subunits (11).
CRP mediates many ofthe same in vitro reactions as the immunoglobulins, yet it differs
from them in terms of antigenicity (8), tertiary structure (11), specificity of induction (3),
and molecular heterogeneity (11, 13) . In contrast to immunoglobulin the C-reactive
protein molecules all share the same binding specificities which are directed toward
phosphate esters (14, 15), especially phosphoryl choline and choline phosphatides (16) ;
additional binding specificities have been reported for certain polyanions (14, 16) and
polycations (17, 18), and even carbohydrate (19) . Like the immunoglobulins CRP
possesses the ability to initiate reactions of precipitation (2, 20), agglutination (21),
capsular swelling (22), promotion of phagocytosis (23, 24), and complement consumption
(17, 25) . CRP and the immunoglobulins have a similar amino acid composition (11, 13)
although the amino acid sequence of CRP is yet to be determined. Indeed, as a
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multivalent protein capable of reacting with and aggregating a variety of exogenous and
endogenous substances on the one hand, and activating or influencing host effector
mechanisms such as complement on the other, CRP is remarkably similarfunctionally to
the immunoglobulins . These and related properties of CRP, such as enhancing the
random motility of leukocytes (26), have implied a role forCRP in nonspecific resistance
to infection (27) as well as in modulation of tissue injury and repair . It also has been
suggested that CRP may be involved in the induction of specific immunity since CRP
levels after adjuvant treatment correlated well with subsequent antibody titers (28) . It
therefore was of interest to define the reactivity of CRP with the cells of the lymphoid
system .
Reports on the effect of CRP on lymphocytes have been limited and conflicting .
Hornung and Fritschi (29) reported that CRP added to leukocyte suspensions
was mitogenic at low concentrations (10 )ug/ml) but toxic at higher concentra-
tions . Hornung (30) later reported that CRP in the presence of lymphocytes
inhibited the growth of human melanoma cells in vitro . By contrast, Hokama et
al . (31) reported that purified CRP and CRP-containing sera were not mitogenic
to lymphocytes but rather inhibited their mitogenic response to phytohemag-
glutinin (PHA) ; they suggested that CRP was one serum constituent responsible
for the depression of the lymphoblastogenic response to mitogens that is observed
'in many disease processes . The present studies thus were undertaken to more
clearly define the interactions between CRP and the lymphoid system, to
determine whether CRP could interact with either T or B lymphocytes
selectively, and to examine the consequences of any such interactions on
lymphocyte functions in vitro.
We report here that CRP binds selectively to T lymphocytes, inhibits their
ability to form spontaneous rosettes with sheep erythrocytes (E) and inhibits
their response to allogeneic cells in mixed lymphocyte culture (MLC) reactions .
By contrast CRP does not bind to B lymphocytes, and does not alter such B-cell
functions as binding to activated complement components (C3b) or to the Fc
portion of immunoglobulin, or the mediation of antibody-dependent cytotoxicity
reactions . Furthermore, CRP fails to inhibit PHA or concanavalin A (Con
A)-induced mitogenesis . It therefore seems that binding of CRP is a property of'T
lymphocytes or a subpopulation thereof', and can result in modulation of certain
of the T-cell functional characteristics in vitro .
Materials and Methods
Purification of C-Reactive Protein (CRP) .
￿
CRP was purified from ascites or pleural fluids by
affinity column chromatography based on the calcium-dependent binding of CRP to CPS (3, 7, 8) .
The CPS was extracted from a Cs-encapsulated pneumococcal mutant (generously provided by Dr.
Gerald Schiff'man, Department of Microbiology, DownstateMedical Center, Brooklyn, N. Y.) by the
method of Anderson and McCarty (32), and attached to cyanogen bromide-activated Biogel-A-50m
beads (Bio-Rad Laboratories, Richmond, Calif.) . CRP-rich ascites or pleural fluids were passed
through this column in calcium-containing Tris-buffered saline, pH 7.4, and the CRP was eluted as
a single protein peak with citrate-buffered saline . The protein-containing fractions were pooled and
filtered through a Biogel-A-0 .5 m (Bio-Rad Laboratories) column to remove CRP aggregates and
subunits . The eluted CRP was dialyzed overnight against normal saline and sterilized by Millipore
filtration . Analysis ofthese preparations by immunoelectrophoresis developed with antihumanwhole
serum/CRP revealed a single line having gamma mobility . A single protein band was also seen onR . F. MORTENSEN, A . P. OSMAND, AND H. GEWURZ
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polyacrylamide gel electrophoresis . Monospecific antisera to thisCRPhave been raised in both goats
and rabbits . The procedure for this purification will be published in detail elsewhere.'
Separation andIdentification of Peripheral BloodLymphocytes (PBL) .
￿
Lymphocytes in heparin-
ized blood from normal individuals were separated by centrifugation on Ficoll-Hypaque . The cells
were washed twice in RPMI-1640containing antibiotics, glutamine (2 mM), and 10% heat inactivated
agammaglobulinemic fetal calf serum (FCS) (Baltimore Biological Laboratories, Cockeysville, Md .)
and resuspended to 106/ml. Cell viability as determined by dye exclusion was usually greater than
98% and contamination by neutrophils was always less than 4% .
The E-rosette test for SRBC binding by T lymphocytes (33) was carried out by mixing 0.5 ml
lymphocytes (2 x 10 6/ml) in Hanks' balanced salt solution (HBSS) with 0.5 ml of 0.5% SRBC and0.1
ml inactivated FCS (absorbed with SRBC) . The mixture was centrifuged at 150 g for 5 min at room
temperature and kept at 4°C for 2-18 h before counting . TheEAC rosette test wasused to measurea
B-cell subset having receptors for C3bor C3d (34, 35) . EAC were prepared by incubating hemolysin
(rabbit 19S anti-SRBC)-sensitized E with a 1:25 dilution of normal human serum for 1 h at 37°C and
washing the unlysed cells five times in HBSS . A mixture of 0.5 ml of 0.5% EAC and 2 x 10 6
lymphocytes were incubated on a rotary wheel for 30 min at 37°C as described by Ross et al . (35) .
Both E and EAC rosettes were scored as positive when binding three or more SRBC ; 100-200
lymphocytes were examined in each sample .
Bcells were purified by removing Tcellswhich hadformed rosettes withSRBC (36) . T-cell rosette
formation was carried out as described above except volumes of all reactants were multiplied by 4.
The mixturewas layeredon Ficoll-Hypaque andcentrifuged for20 min at 400g at 4°C. Lymphocytes
at the interface were collected and stained with polyvalent fluorescein isothiocyanate (FITC)-conju-
gated antisera to IgG, IgA, and IgM (anti-GAM) (Hyland Div., Travenol Laboratories, Costa Mesa,
Calif.) to determine the fraction of B cells present . This procedure enriched the fraction of surface
immunoglobulin (1g)-bearing cells from 20-30% to 75-90% .
T cells were enriched from PBLsuspensions by removingB cells by filtration through a nylon wool
column (37) . The column was packed with 300mg of nylon fiber (Fenwall Leukopak, DownersGrove,
Ill.) to the 5 ml mark in a syringeand preincubated with RPMI-1640 containing 10% FCS at 37°C for
10 min. PBL (10') were added and the column was incubated for 60 min at 37°C . T cells were eluted
with 15-20 ml medium at 1 ml/min . The number of Ig-bearing cells was reduced to 5% or less .
Immunofluorescent Staining for CRP. PBL (106 cells in 1.0 ml) were incubated with CRP in
RPMI-1640containing 10% FCS at 37°C in a 5% CO,atmosphere . The cells were washed three times
with 5 vol of RPMI-1640containing 10% FCS. Fluoresceinated (Fl)-rabbit antihuman CRP (Behring
Diagnostics, Somerville,N. J .) was added to a 0.1 ml suspension of lymphocytes in phosphate (0.01
M)-buffered saline (PBS), (pH 7.2) which contained 1.0% bovine serum albumin (BSA) and 0.01M
sodium azide . After staining for 30 min at 4°C the cells were washed three times in PBS-BSA, and
examined using a Leitz Orthoplan photomicroscope (E . Leitz, Inc., Rockleigh, N. J .) under 400 x
magnification by incident light fluorescence with either FITC or BG38 excitation filters . The
percentage of cells binding CRP was determined by relating the number of fluorescent cells to the
total number of cells in each field as visualized by dark-field illumination . Routinely at least 200
lymphocytes/sample were examined . Specificity of fluorescence was established with controls
consisting of both cells incubated without CRP and cells treated with an excess of unconjugated
anti-CRP followed by incubation with conjugated anti-CRP . Indirect fluorescent staining was
performed by adding unconjugated rabbit anti-CRP followed by Fl-goat antirabbit gamma globulin
(Cappel Laboratories, Dowington, Pa .) . The purity of the Fl-anti-CRP rabbit antiserum was tested
by immunoelectrophoresis against acute phase serum, normal serum, and purified CRP. A single
fluorescent precipitation arc was seen when acute phase sera or CRP were analyzed .
Lymphocyte Cultures .
￿
Human lymphocyte suspensions (106 in 0.1 ml) in RPMI-1640 containing
10% FCS were cultured in microplates (Microtest II, Falcon Plastics, Div. of BioQuest, Oxnard,
Calif.) in the presence of varying dilutions of the mitogens, PHA (PHA-P, Difco Laboratories,
Detroit, Mich .) and Con A (Nutritional Biochemical Co ., Cleveland, Ohio) . 50 kl of the appropriate
dilution ofPHA or Con A wasadded to the cultures . CRP diluted in mediawasalso added . Cells were
sOsmand, A. P., R . F. Mortensen, J . Siegel, and H. Gewurz . Interactions of C-reactive protein
with the complement system . III . Complement-dependent passivehemolysis initiated by CRP . Manu-
script in preparation .824
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cultured for 96 h, pulsed with 0.5,uCi of ['H]thymidine (1.9 Ci/mmol; Schwartz Mann Div., Becton,
Dickinson & Co., Orangeburg, N. Y.) for 18 h, and harvested on a multiple sample harvester as de-
scribed by Hartzman et al. (38).
Unidirectional MLC reactions were conducted according to the method of Hartzman et al. (38) .
Responding cells (105 in 0.1 ml) were added to 2 x 105 mitomycin-C (Calbiochem, SanDiego, Calif.)
(25 mg/ml, 30 min)-inactivated stimulating cells in a total vol of 0.2 ml in microculture plates. Cells
were suspended in medium 199 (M-199) with antibiotics (Pen-Strep 100 U/ml, Difco Laboratories)
containing 20% heat-inactivated AB human serum (Grand Island Biological Co., Grand Island, N.
Y.). CRP was diluted in M-199 containing 20% AB serum before addition to the cultures. Theplates
were incubated for 5 days, pulsed with 0.5 pCi ['Hlthymidine/well and harvested 18 h later.
Detection of Lymphocytes with Fc Receptors. Fl-aggregated human gamma-globulin (Cohn
Fraction II) (Fl-AHGG) was prepared exactly as described by Dickler andKunkel (39) . Lymphocytes
(106/ml) were incubated (16 h) with CRP or CRP-CPS complexes, washed with PBS-BSA (pH 7.2),
incubated with the Fl-AHGG (1 mg/ml) for 30 min at 23'C and examined for fluorescent patches on
the cell surface (40) . Percentages were based on examinations of at least 200 lymphocytes.
Antibody-Dependent Lymphocyte-Mediated Cytotoxicity (ADL) . Assessment of ADL was
determined by using the assay system described by Zighelboim et al. (41) . Antiserum to the EL-4
lymphoma of the C57BL/6 mouse strain was prepared in rabbits by injecting 5 x 108 cells at multiple
sites subcutaneously, boosting with three weekly intravenous injections of 108 cells, and bleeding the
animals 10-14 days after the last injection. This antisera hada cytolytic titer (50% lysis) of 1 :2560 when
tested against Cr5 `-labeled EL-4 cells (106) in the presence of absorbed rabbit complement (1:10).
EL-4 (10') grown in ascites form were labelled with 100,uCi Cr"(sodium chromitope, E. R. Squibb,
Chicago, Ill.) in RPMI-1640 at 37°C for 60 min. A dilution of the antiserum in 0.1 ml was added to 5
x 10' EL-4 cells and 2 x 106 lymphocytes (PBL) in a total reaction volume of 0.5 ml in a (Linbro
Chemical, New Haven, Conn.) tissue culture tray. The tray was incubated on a rocking platform for 3
h at 37°C in 5% CO,, the cells were centrifuged, and 0.1 ml was counted for Cr" release. Percent
specific lysis wascalculated from the following equation: (cpm-background cpm/maximum releasable
cpm-background cpm) x 100. The maximum releasable cpm were obtained by adding 0.2 ml rabbit
complement (absorbed with EL-4) to a mixture of 0.1 ml of the anti-EL-4 antiserum and 5 x 10'
EL-4 cells in 0.5 ml. This release wasusually 80-90% ofthe total number of counts incorporated.
Mice, Anti-6 Antiserum. Female DBA/2, C57BL/6 and BALB/c mice were purchased from
Jackson Laboratories, Bar Harbor, Maine). Athymic nude (nu/nu) mice and heterozygous (nu/+)
littermates were agift from Dr. Jerry Winkelstein, Department of Pediatrics, Johns HopkinsMedical
School, Baltimore, Md. Anti-B antisera (C3H specificity) (Litton Bionetics, Kensington, Md.) was
used to both determine the fraction of 0-bearing cells and to lyse spleen T cells . The number of
0-bearing spleen cells was determined by Crs' release from lymphocytes incubated with anti-B
antisera (1 :10) for 30 min in PBS containing 1% BSA, then centrifuged and resuspended in a 1:5
dilution of absorbed rabbit complement (42). Thesame procedure with unlabeled cells in RPMI-1640
containing 10% FCS was used to remove 0-bearing cells .
Lymphoid Cell Lines.
￿
A human B-cell line (HRIK) andamarmoset T-cell line (1022) were kindly
provided by Dr. Larry Falk of the Department of Microbiology of this institution. The T- and B-cell
characteristics of these cell lines have been previously documented (43) .
Results
Binding of CRP to Human Peripheral Blood Lymphocytes.
￿
We first sought to
determine whether CRP could bind directly to human lymphocytes. Washed
PBL were incubated with CRP and reacted with fluoresceinated anti-CRP. This
consistently resulted in a patchy fluorescence on the surface of many small and
medium size lymphocytes (Fig . 1) . There was no apparent "capping" or
redistribution of the bound CRP, even in the absence of azide. Indirect
immunofluorescent staining with Fl-goat antirabbit Ig did not noticeably change
the staining pattern nor did it induce redistribution.
The fraction of normal human PBL that could bind CRP was proportional toR. F . MORTENSEN, A. P . OSMAND, AND H . GEWURZ
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FIG. 1 .
￿
Photomicrographs of lymphocytes showing typical patchy staining pattern on the
cell surface afterincubation with CRP (50 kg/ml) and reacting with fluoresceinated anti-CRP .
Approximate magnification : (a) x 450. (b) x 900.
the amount of purified CRP added to the lymphocyte cultures up to a
concentration of 10 Wg/ml ; a maximum of 35-40% of the cells were stained (Fig .
2) . The binding of CRP was specifically inhibited if theCRPsubstrate, CPS, was
added at the time the cultures were initiated. Normal PBL showed background
staining of less than 2-3% when Fl-anti-CRP was added in the absence of
preincubation with CRP . Although the cultures of lymphocytes and CRP were
usually incubated for 16 h, an equal fraction of cells were stained after 3 h of
incubation and a smaller fraction if incubated 2 h or less, Since PBL usually
contains less than 30% cells staining for membrane Ig (B cells) it was apparent
that CRP was binding to at least some T cells .
Specific Binding of CRP to T lymphocytes.
￿
The question arose as to whether
there is a specificity of CRP for either the T- or B-lymphocyte populations.
Recently devised marker systems and separation methods for human T and B
cells provide a direct approach to establishing selective binding.
Two different methods were used to separate human PBL into T- and B-cell
enriched fractions before testingeach population for thepresence ofCRP-binding
cells . In the first, B cells were enriched by removing T cells as E rosettes on
Ficoll-Hypaque gradients and using the cells collected at the interface . The . data
from several such separations indicated that a single cycle of purification
increased by threefold the number of Ig-bearing and complement receptor-bear-
ing lymphocytes (CRL) . This procedure correspondingly lowered the fraction of
cells able to bind CRP (Table I) . In the second approachB cells were removed on
nylon wool columns, thus enriching the effluent lymphocytes inT cells as shown826 EFFECTS OF C-REACTIVE PROTEIN ON T LYMPHOCYTES
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The binding of purified C-reactive protein (CRP) to peripheral blood lymphocytes
(PBL) in vitro. PBL (106/ml) were incubated for 16 h with various concentrations of CRP
("-0), washed and stained with FITC-conjugated rabbit-anti-CRP; up to 40% of the cells
showed patchy fluorescence (CRP-POS). CPS (10 kg/ml) was added in duplicate cultures
with CRP(O-0) andprevented CRPbinding.
TABLE I
Binding of Purified CRP by Peripheral Blood Lymphocytes and B-Cell and T-Cell
Enriched Populations
*Determinations performed simultaneously with unf'ractionated and fractionated lymphocytes from
each of eight healthy donors.
$ Cells stained with FITC-conjugated polyvalent anti-GAM antisera. Mean t SE.
§ Cells incubated with CRP for 16 h aftertheseparation procedures and stained with FITC-conjugated
anti-CRP sera. Mean t SE.
by the increase in rosette-forming cells and the decrease of Ig-bearing cells (Table
I) . Upon incubation with CRP a significantly larger fraction of cells were stained
for CRP than in the original population. Taken together these results indicate
that CRP binds preferentially to the T-cell population .
Additional experiments testing the ability of CRP to bind to a human B-cell
line and a marmoset T-cell line were conducted . A human B-cell line, HRIK,
transformed by Epstein-Barr virus displayed minimal (10-15% stained cells)
binding of CRP. However, a transformed marmoset T-cell line that formed
rosettes (90-100%) with SRBC (43) displayed a high degree of CRP-binding
(60-80% of the cells) . These results )end further support to the T-cell specificity
of CRP-binding.
Experiments were undertaken to examine the binding of human CRP to mouse
spleen lymphocytes . The fractions of 0-bearing cells in spleens of DBA/2,
C57BL/6, and BALB/c mice as determined by Cr" release with anti-B antiserum
Lymphocyte
preparation* E-R f SE POS
surface Ig$
EAC-R
t SE
CRP-POSafter
incubation
with CRP§
Peripheral bloodlymphocytes 58.5 t 4.4 27.0 t 2.8 21 t 6.1 34.4 t 4.0
13-enriched, single cycle (E- - 80.6 -±:7 .6 55.316.8 10.8 12.3
rosette)
T-enriched (nylon wool column) 69.0 t 6.6 3.8 t 1.8 1-2 49.8 t 6.7R. F . MORTENSEN, A. P . OSMAND, AND H . GEWURZ
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and complement were similar to those reported by others (44) . The removal of
mouse spleen T cells by anti-B sera plus complement led to a decreased
percentage of cells able to bind CRP upon subsequent incubation (Table II) . The
residual number of CRP-binding cells following treatment with anti-8 plus
complement may reflect unlysed T cells. In addition, spleen lymphocytes from
congenitally athymic (nu/nu) nude mice contained only a small number of
CRP-binding cells, whereas spleens from heterozygous littermates (nu/+) had a
fraction of CRP-binding cells similar to that of the other three strains tested .
These manipulations indicate that human CRP can also bind to theT cells of a
heterologous species .
TABLE II
Binding of Purified Human CRP to Mouse f)-Bearing Spleen
Lymphocytes
CRP-POS aftertreatment
with :
*Percent 0-positive determined by Crs` release aftertreatment with anti-6
(1 :10) andrabbit complement .
$ 0-bearing spleen cells (106) were lysed with anti-B and rabbit comple-
ment in RPMI-1640 containing 10% FCS. The remaining cells were
incubated withCRPandstained for CRPas in Fig . 1 .
§Athymic nude (nu/nu) mice on a Swiss-NIH background as well as
heterozygous (nu/+) littermates were tested .
Effect of CRP on the Formation of Human T- and B-Cell Rosettes .
￿
During
attempts to show the presence of CRP on rosetted T cells (E rosettes ; E-R), we
found that preincubatinghumanPBL with CRP inhibited rosette formation (Fig .
3) . To study this reaction, separated lymphocytes were incubated with various
concentrations of CRP, washed free of unbound CRP, and tested for ability to
form rosettes with E. Inhibition of rosette formation proportional to the
concentration of CRP added was seen ; it was fully neutralized when small
quantities of CPS were included in the incubation mixture with CRP. Efforts to
stain residualE rosettes forCRP on their surface were unsuccessful ; indeed, most
of the staining cells had few or no attached E .
A marker for B cells expressing a receptor for C3b or Cad is the formation of
stable rosettes with EAC (34, 35) . Incubation of PBL with CRP did not alter the
ability of CRL to form rosettes with EAC (Fig . 3) . Thus, CRP inhibited rosette
formation byT cells but not by CRL (B cells) . Since it has been found that not all
B lymphocytes express the C3 receptor (35), experiments to test the effect of
Strain B-positive*
Media
Anti-B +
complement$
DBA/2 42 30 7
C57BL/6 46 33 11
BALB/c 51 41 14
nu/nu§ 2 11 ND
nu/+ 43 35 ND828
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CRP Ng/ml
FIG. 3 . The effect of CRP on the formation of T-cell rosettes (E-R) ("-" ) . Peripheral
bloodlymphocytes were incubated with increasing concentrations of CRP, washed, and mixed
with sheep erythrocytes ; the percent rosette-forming cells was determined . CPS (20 Ag/ml)
added at the same time as CRP neutralized the inhibition of E-R (A-A). Theeffect ofCRP on
the formation of rosettes withEAC byPBL(O-O) using thesame culture conditions wasalso
determined . The results are expressed as the mean zE SE .
CRP on binding to other B-cell receptors were performed and are described in
subsequent sections .
Effect of CRP on the Response of Human PBL to Mitogens . It seemed
possible that binding of CRP toT lymphocytes might alter their response to the
T-cell-specific plant lectins, PHA and Con A. The results of incorporating CRP
into lymphocyte cultures along withPHA or Con A at the time of their initiation
are shown in Figs . 4 and 5, respectively . A consistent but statistically insignifi-
cant (Student's t test) enhancement of the response was observed over a wide
range of mitogen concentrations when CRP was added at doubling concentra-
tions between 1.25 and 20.0 leg/ml . Since enhancement was observed at each CRP
concentration only the data for 10 Ag/ml CRP is shown in the figures. The lack of
statistical significance may be a reflection of the variation in responsiveness of
lymphocytes from different donors .CRP was notsignificantly mitogenic by itself',
nor was it toxic for peripheral lymphocytes up to 100 tLg/ml since "background"
[3H]thymidine incorporation was equal to that of the controls (Table 111) . When
CRP toxicity was assayed directly by determining the percent viable cells in cul-
ture by trypan blue dye exclusion, no significant differences from the control cul-
tures were observed . Comparisons by direct cell counting gave similar results.
These results strongly indicate that the action exerted by CRP onT cells does
not involve toxicity .
Effect of CRP and CRP-CPS Complexes on the Binding of Aggregated
Ig . SinceCRP can consumeC after bindingto its substrates (17, 18, 25), it may
possess a region functionally analogous to the Fc portion of Ig . A receptor for the
Fc portion of aggregated IgG or antibody complexedto antigen has been shown to
exist on most or all human B cells (40) . Because of the many sharedR. F. MORTENSEN, A. P . OSMAND, AND H . GEWURZ
FIG 4. The effect of CRP on the response of PBL to PHA. The abscissa represents the
equivalent volume of undiluted stockPHA per culture . CRP (10kg/ml) was added 1 h before
theaddition of the appropriate PHA dilution . The stimulation index is expressed as the mean
(=i-SD) of cultures of lymphocytes from 7-10 healthy donors tested against the PHA
concentrations shown.
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FIG . 5 .
￿
The effect ofCRP on the response ofPBL to ConA. CRP was added at 10 ug/ml 1 h
before the addition of the appropriate Con A dilution . The stimulation index is the mean
(tSD) of cultures of lymphocytes from 5-8 healthy donors.
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characteristics of Ig and CRP, we tested the ability of CRP or CRP-CPS to
inhibit the binding of Fl-aggregated Ig . The results in Table IV indicated that
neitherCRP nor CRP-CPS interfered with the binding of aggregated Ig toB cells .
The fraction of cells binding aggregated Ig correlated closely with the number of
cells with membrane Ig . Thus, it appears that CRP does not bind to the Fc
receptor of B lymphocytes .
Effect of CRP and CRP-CPS Complexes on Antibody-Dependent Lym-
phocyte-Mediated Cytotoxicity . An important function oflymphocytes with Fc
receptors is antibody-dependent lymphocyte-mediated cytotoxicity (ADL) (42) .
This cytolysis can occur with as few as 10-100 IgG antibody molecules pertarget
cell (41, 45) and therefore should be readily inhibited by substances binding to830
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TABLE III
TheEffect of C-Reactive Protein on [aH]ThymidineIncorporation
and Viability of Lymphocytes
* The range ofCRP concentrations (2.5-100 Ag/ml) were tested with cells
from each donor .
$ Cultures were labeled on day 3 and harvested 18 h later .
§Percent viability by trypan blue dye exclusion .
the Fc receptor . We therefore tested the inhibitory activity of CRP or CRP-CPS
complexes on an ADL system consisting of rabbit antibody-coated EL-4
lymphoma target cells and PBL at a lymphocyte/target cell ratio of 40:1 (see
Materials and Methods) . As can be seen in Fig . 6, neither CRP nor CRP-CPS
complexes inhibited cytolysis at even very high dilutions of anti-EL-4, where
competition for Fc receptors would be most apparent . Since EL-4 is 0-bearing
(46) and binds CRP as shown by fluorescent staining, attempts were made to lyse
CRP-coated EL-4 cells with the addition of lymphocytes . CRP alone was not able
to mediate this cytolytic reaction even at very high lymphocyte to target cell
ratios (100 :1), whereas maximum cytolytic activity with a 1:10 dilution of
anti-EL-4 occurred at a lymphocyte/target cell ratio of 40 :1 (data not shown) .
These results imply that CRP and CRP-CPS complexes do not mediate
lymphocytotoxicity or inhibit ADL via binding to the Fe receptor of B
lymphocytes .
Effect of CRP on the Mixed Lymphocyte Reaction .
￿
Since CRP could bind to
T cells without eliciting a blastogenic response or significantly influencing the
response to T-cell mitogens, it seemed important to test the effect of CRP upon
the one-way MLC reaction, a T-cell function involving recognition of allogeneic
cells and readily measureable with human PBL. We found that CRP, added
directly to the MLC reaction mixtures, markedly inhibited the proliferative
response (Fig . 7) . This inhibition was proportional to the CRP concentration over
the dose range of 5-100 ug/ml ; at 100 leg/ml the MLC response was only 10-
20% of that of controls . These experiments have been repeated with eight differ-
ent allogeneic combinations using each of the CRP concentrations, and similar
results have been obtained . Parallel experiments measuring trypan blue exclu-
sion by the responding cells in medium 199 containing 20% AB serum and CRP
CRP No
donors
. of
§
Stimulation
index (--SD)
+CRP/no CRP$
Viability§
24 h 48 h
gag/ml %
- 19 1 .00 95 90
2.5 17 1 .17 t 0.69 - -
5.0 20 1 .14 -±:0 .64 96 91
10 19 1 .26 :±:0.79 95 89
20 12 1 .29 f 0 .77 95 92
30 12 1 .40 t 0.70 - -
50 6 0.89 f 0.35 93 90
100 6 1 .07 t 0.56 94 91R . F. MORTENSEN, A . P. OSMAND, AND H. GEWURZ
TABLE IV
Failure of CRPAlone or CRP-CPS Complexes to PreventBinding
of Aggregated IgG to Human PBL
* Percentage of cells staining with polyvalent Fl-anti IgG, IgA, and IgM
(anti-GAM) .
$Cells tested for binding of FITC conjugated aggregated Ig after incuba-
tion (16 h) with CRP or CRP-CPS mixtures. At least 200 cells were
examined at each CRP concentration .
6
O
80
60
20
0
Control
o 100fLql CRP/ml
* 40/cg CRP/ml
X 40ug CRP/ml
tug CPS/ml
-3 -4 -5 -6 -7
Anti-EL-4 Dilution(log io )
%Positive
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FiG. 6 . The effect of CRP and CRP-CPS mixtures on antibody-dependent lymphocyte-
mediated cytotoxicity . CRP at 100 ug/ml (O) or 40 ug/ml (A), or CRP (40 ug/ml)-CPS
(2 ug/ml) complexes (X) were added to assay mixtures of EL-4 target cells coated with increas-
ing dilutions of rabbit anti-EL-4 (IgG) and PBL at a lymphocyte/target cell ratio of 40 :1 . The
percent specific cytolysis (-LSD) was calculated as described in MaterialsandMethods.
Exp. CRP
ug/ml
CPS
ug/ml
Surface
Ig$
Aggregated
Ig$
A - 26 23
50 20
100 20
200 21
100 5 24
B - 20 18
50 17
100 16
200 19
100 5 15832
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FIG. 7.
￿
Theeffect of CRP on the response ofhumanlymphocytes to allogeneic lymphocytes in
a one-way mixed leukocyte culture reaction. Responding lymphocytes (1 x 106) were
stimulated with 2 x 106 mitomycin-treated allogeneic lymphocytes (designated "m") in the
presence of various concentrations of CRP, or CRP and CPS. The data shown is from a single
allogeneic combination and expressed as mean cpm (tSD).
at the various concentrations revealed no significant alteration of cell viability.
Furthermore, cells failing to respond in the MLC could respond to PHA after
they were removed from the CRP-containing medium. The addition of CPS at
the time the cultures were initiated could prevent at least partially the inhibi-
tory effect exerted by CRP (Fig. 7) . The ratio of CPS to CRP was chosen on the
basis of optimal proportions forboth precipitation and complement consumption,
which were found to be approximately 1:20 (15, 25). CPS alone did not signifi-
cantly alterthe MLC response.
Since CRP could conceivably inhibit the MLC response by binding to either
the stimulating or responding cells or both, we briefly (3 h) exposed the
stimulating and responding cells, respectively, to CRP before adding each to the
MLC. As shown in Table V, preincubation of the responding lymphocytes with
CRP in medium 199 containing 20% AB serum, followed by the removal of
unbound CRP, resulted in a lowered MLC response. However, considerably
higher concentrations of CRP were required in the preincubation mixture to
obtain a degree of suppression equivalent to that observed when CRP was added
directly to the cultures (Fig . 7) . Similar experiments in which the mitomycin C
inactivated stimulating cells were preincubated with CRP did not lower the MLC
response (Table V) . Thus, these observations clearly indicate that CRP is
capable of modifying the recognition and/or proliferative phases of the response
to allogeneic cells.R. P . MORTENSEN, A. P. OSMAND, AND H. GEWURZ
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TABLE V
The Effect of Preincubating the Responding or Stimulating Cells with CRPon MLC
Responsiveness
* Responding or stimulating cells were incubated with the indicated concentration ofCRP for 3 h at
37°C, washed twice, and added to the cultures .
$ Cells were incubated with CRP after mitomycin C inactivation .
Discussion
CRP is a homogeneous protein, which is structurally and antigenically distinct from the
immunoglobulins, but shares several of their functional characteristics (2, 14-25) . Its
similarity to antibody, as well as the association of CRP with host functions involved in
"nonspecific" resistance to infection (26, 27) and its potential influence on the induc-
tion of antibody formation (28), have led us to initiate studies to determinetherelationship
betweenCRPandthelymphoid system .
Several lines of evidence indicated that CRP binds selectively toT lymphocytes .
Incubation of normal human peripheral blood lymphocytes with human CRP,
followed by addition of FITC-conjugated anti-CRP, resulted in patchy staining of
the surface of 30-40% of the cells . When B cells were removed on nylon wool
columns, the remaining lymphocytes had an increased fraction of cells capable of
binding CRP ; conversely, when T cells were removed asE rosettes, a decreased
percentage of CRP-binding cells remained . Similar results were obtained when
murine lymphocytes were exposed to CRP. Approximately 40% of the splenic
lymphoid cells from several mouse strains were able to bind human CRP ; this
fraction was reduced by more than 80% after treatment with anti-B serum and
complement . Furthermore, only 11% of the spleen cells of athymic nude mice
were capable of bindingCRP. Finally, a marmoset T-cell culture line displayed a
high degree of CRP binding while only a small fraction of cells of ahuman B-cell
line could bind CRP. Thus, human CRP binds preferentially to T lymphocytes .
Since CRP reacts with T cells but not B cells, it may prove to be a marker for a
subpopulation of T cells, but further experiments are needed to establish this
point .
CRP also was found to selectively inhibit certain T-cell mediated functions .
Cells
preincubated* CRP
Cell
combination
[3H]-
thymidine
% of
control
AgIml cpm
Responding - AAm 555
cells (A) - AB_ 4,190
50 AB_ 3,458 83
100 ABm 2,928 69
200 AB. 2,370 57
Stimulating - AAm 584
cells (B.)f - ABm 4,376
50 ABm 4,332 99
100 ABm 5,937 136
200 ABm 4,463 102834
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Preincubation of human peripheral blood lymphocytes with small noncytotoxic
amounts of CRP resulted in their inability to show characteristic binding to
sheep erythrocytes ; yet similar amounts of CRP had no effect upon B-cell binding
of complement-coated erythrocytes (EAC) or aggregated IgG. CRP also was
effective in inhibiting blastogenesis in unidirectional MLC reactions. The
inhibition of both T-cell rosette formation and MLC reactivity was neutralized
by adding the CRP substrate, CPS . Preincubation of CRP with stimulating cells
had no effect on subsequent MLC reacitivity, while preincubation with respond-
ing cells inhibited the proliferative response to allogeneic cells . This specificity
for the responding cells was not altogether unexpected since recent reports have
shown that stimulating cells in human MLC reactions consist largely of B cells
whereas the responding cells are largely or entirely T cells (47, 48) . Since
proliferation in the MLC reaction is a prerequisite for the generation of cytotoxic
cells (49) it seemed likely that the generation of effector T cells would be
inhibited by CRP as well; preliminary studies suggest that this is the case .'
CRP shares with certain antibodies the ability to inhibit the MLC reaction, but CRP does
so exclusively at the level of the responding cells . Anti-HL-A sera have been shown to
inhibit at the level of both stimulating and responding cells (50-52) and may be directed
not only to HL-A but also to receptors for the products of the MLC loci (reviewed in 53) .
The CRP-induced inhibition of the MLC response was similar to that seen by Wernet and
Kunkel using certain sera from patients with systemic lupus erythematosus (54) . These
sera were found to inhibit the responding but not the stimulating cells, possibly by
combining with the T-cell receptor for lymphocyte defined (LD) antigens. Whether CRP
interferes by binding to recognition units for LD antigens is not yet clear. Since CRP
binding resulted in a patchy surface staining without redistribution, even when unconju-
gated anti-CRP followed by fluoresceinated goat antirabbit gamma globulin was used, the
CRP-binding sites seem to be distantly spaced and/or fixed, perhaps in the choline
phosphatide-containing lipid component of the membrane (13, 15, 25) . However, we do
not yet know the chemical nature of the CRP receptor, its distribution on T-cell
subpopulations, or its relative availability during the life cycle of either intact or damaged
T lymphocytes. The binding of CRP could inhibit T-cell functions in several ways,
including steric hindrance of interactions with other cell surface components, elevation of
cyclic AMP levels which already have been correlated with inhibition of T-cell rosette
formation (55) or activation of "suppressor T cells" which regulate the response to
allogeneic cells (56, 57) . We do not yet have experimental support to favor any of these
several hypotheses.
CRP did not inhibit all T-cell-mediated functions. It had no inhibitory effect on
stimulation of lymphocytes by PHA or Con-A over a wide range of CRP and mitogen
concentrations; indeed, a minimal but distinct enhancing effect on response to these
T-cell specific mitogens was observed. It did not have toxic or mitogenic activities of its
own. CRP had been reported by one group (29) to be mitogenic to lymphocytes at low
doses ( <10 mg/ml) and cytotoxic at higher doses, and by another group (31) to have an
inhibitory effect upon PHA-induced mitogenicity at higher concentrations. The disparity
between our results and those previously reported is not clear; perhaps it pertains to the
nature of the C-reactive protein preparation, the presence of granulocytes in lymphocyte
preparations, culture conditions or other factors. The slight enhancing effect of CRP on
PHA- or Con A-induced mitogenesis, concomitant with inhibition of formation of T-cell
rosettes and proliferation in the MLC reaction, suggests that CRP either has no effect
s Mortensen, R. F., D. Claus. A. P. Osmand and H. Gewurz Manuscript in preparation.R. F . MORTENSEN, A. P . OSMAND, AND H. GEWÜRZ
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upon subpopulations ofT cells involved in the response to these mitogens, or that it acts in
events of the recognition phase which are not required for PHA or Con A responsiveness .
The effects on other T-cell functions such as lymphokine release and soluble antigen-
induced blastogenesis have not yet been determined .
In contrast to the reactivity between CRP and T cells, multiple lines of evidence
indicated that CRP has minimal, if any, effect on B lymphocytes . No binding ofCRP was
detected on separated B lymphocytes incubated with concentrations of CRP up to 200
Ag/ml . Preincubation with these concentrations of CRP failed to influence the binding to
B lymphocytes of either FITC-conjugated AHGG or sensitized sheep cells bearing
complement components . CRP failed to initiate or inhibit antibody-dependent lym-
phocytotoxicity reactions, a function dependent upon cells with Fc receptors (45) . Finally,
CRP failed to inhibit the stimulating cells in the human MLC reaction which are
considered to be primarily B cells (47, 48) . We therefore conclude that CRP has minimal,
if any, direct effect upon B lymphocytes, and that ifCRP influences these cells, it is apt to
do so indirectly . We had thought that since CRP shares with immunoglobulins the ability
to activate complement at the level of Cl (17, 25), it might share a structural homology
with the Fc fragment of IgG, which could result in interference with lymphoid cell
functions dependent on the presence of Fc receptors . This obviously was not the case .
Since the complement reacting region on IgG with Clq involves the CH, domain (58, 59),
whereas the region on IgG required for binding to the Fc receptor on B lymphocytes is in
the CHa region (45), a structural similarity between the CH, region of IgG and CRP still
seems possible . Further interpretation awaits determination of the amino acid sequence
and structure of C-reactive protein .
The relationship between the acute phase reactants including CRP and the
control of immunologic mechanisms is not yet fully known . We do not know the
effects of elevated levels of CRP in vivo on T-cell distribution and function . The
spectrum of cells of both lymphoid and nonlymphoid varieties with which CRP
binds, as well as the conditions and consequences of these interactions, seem
likely to be of great importance in the inflammatory process . Perhaps an
examination of the effect of acute phase serum reactants such as CRP on immune
mechanisms will help explain certain phenomena which accompany the induc-
tion of the inflammatory response, including elevated levels of natural anti-
bodies, enhanced resistance to infection, enhanced antibody responses, and in
some instances decreased cell-mediated immune responses .
Summary
C-reactive protein (CRP) is an acute phase protein which shares with the
immunoglobulins the ability to induce precipitation and agglutination reactions
and activate the complement system . We report here that purified human CRP
binds selectively to human T lymphocytes, inhibits their ability to form
spontaneous rosettes with sheep erythrocytes and inhibits their response to
allogeneic cells in mixed lymphocyte culture reactions ; it fails to inhibit
phytohemagglutinin- or concanavalin-A-induced mitogenesis . CRP does not bind
to human B lymphocytes, nor does it alter the following B-cell functions : binding
to activated complement components or the Fc portion of immunoglobulins,
mediation of antibody-dependent cytotoxicity reactions or the ability of al-
logeneic cells to stimulate a mixed lymphocyte culture reaction . Human CRP
shows similar selective binding with murine T lymphocytes . It therefore seems836
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that binding of CRP is a property ofT lymphocytes or a subpopulation thereof,
and can result in modulation of certain of the T-cell functional characteristics in
vitro . We suggest that CRPmay play arole in modulating T-cell functions during
the inflammatory state .
The technical assistance of Mr . Gary Covitt is gratefully acknowledged .
Receiued for publication 23 December 1974 .
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